TY - JOUR
T1 - Gold nanostructures
T2 - synthesis, properties, and neurological applications
AU - Zare, Iman
AU - Yaraki, Mohammad Tavakkoli
AU - Speranza, Giorgio
AU - Najafabadi, Alireza Hassani
AU - Shourangiz-Haghighi, Alireza
AU - Nik, Amirala Bakhshian
AU - Manshian, Bella B.
AU - Saraiva, Cláudia
AU - Soenen, Stefaan J.
AU - Kogan, Marcelo J.
AU - Lee, Jee Woong
AU - Apollo, Nicholas V.
AU - Bernardino, Liliana
AU - Araya, Eyleen
AU - Mayer, Dirk
AU - Mao, Guangzhao
AU - Hamblin, Michael R.
N1 - Publisher Copyright:
© 2022 The Royal Society of Chemistry.
PY - 2022
Y1 - 2022
N2 - Recent advances in technology are expected to increase our current understanding of neuroscience. Nanotechnology and nanomaterials can alter and control neural functionality in both in vitro and in vivo experimental setups. The intersection between neuroscience and nanoscience may generate long-term neural interfaces adapted at the molecular level. Owing to their intrinsic physicochemical characteristics, gold nanostructures (GNSs) have received much attention in neuroscience, especially for combined diagnostic and therapeutic (theragnostic) purposes. GNSs have been successfully employed to stimulate and monitor neurophysiological signals. Hence, GNSs could provide a promising solution for the regeneration and recovery of neural tissue, novel neuroprotective strategies, and integrated implantable materials. This review covers the broad range of neurological applications of GNS-based materials to improve clinical diagnosis and therapy. Sub-topics include neurotoxicity, targeted delivery of therapeutics to the central nervous system (CNS), neurochemical sensing, neuromodulation, neuroimaging, neurotherapy, tissue engineering, and neural regeneration. It focuses on core concepts of GNSs in neurology, to circumvent the limitations and significant obstacles of innovative approaches in neurobiology and neurochemistry, including theragnostics. We will discuss recent advances in the use of GNSs to overcome current bottlenecks and tackle technical and conceptual challenges.
AB - Recent advances in technology are expected to increase our current understanding of neuroscience. Nanotechnology and nanomaterials can alter and control neural functionality in both in vitro and in vivo experimental setups. The intersection between neuroscience and nanoscience may generate long-term neural interfaces adapted at the molecular level. Owing to their intrinsic physicochemical characteristics, gold nanostructures (GNSs) have received much attention in neuroscience, especially for combined diagnostic and therapeutic (theragnostic) purposes. GNSs have been successfully employed to stimulate and monitor neurophysiological signals. Hence, GNSs could provide a promising solution for the regeneration and recovery of neural tissue, novel neuroprotective strategies, and integrated implantable materials. This review covers the broad range of neurological applications of GNS-based materials to improve clinical diagnosis and therapy. Sub-topics include neurotoxicity, targeted delivery of therapeutics to the central nervous system (CNS), neurochemical sensing, neuromodulation, neuroimaging, neurotherapy, tissue engineering, and neural regeneration. It focuses on core concepts of GNSs in neurology, to circumvent the limitations and significant obstacles of innovative approaches in neurobiology and neurochemistry, including theragnostics. We will discuss recent advances in the use of GNSs to overcome current bottlenecks and tackle technical and conceptual challenges.
UR - http://www.scopus.com/inward/record.url?scp=85127687368&partnerID=8YFLogxK
U2 - 10.1039/d1cs01111a
DO - 10.1039/d1cs01111a
M3 - Review article
AN - SCOPUS:85127687368
SN - 0306-0012
VL - 51
SP - 2601
EP - 2680
JO - Chemical Society Reviews
JF - Chemical Society Reviews
IS - 7
ER -